Pfizer-BioNTech Covid Shot Cleared for Children in Europe
- First vaccine approved for young teens by Europe regulator
- Germany plans to start vaccinating children from June 7
This article is for subscribers only.
European regulators cleared Pfizer Inc. and BioNTech SE’s Covid-19 vaccine for children ages 12 to 15, preparing the way for mass inoculations of younger teenagers across the continent.
The green light from the European Medicines Agency gives Europe, whose immunization campaign was initially fraught with difficulties, the first vaccine in its arsenal for younger adolescents. The shot was already cleared for people as young as 16.